You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Japan Patent: 5509201


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5509201

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,450,311 May 29, 2029 Harrow Eye MOXEZA moxifloxacin hydrochloride
9,114,168 May 29, 2029 Harrow Eye MOXEZA moxifloxacin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP5509201

Last updated: July 28, 2025


Introduction

Japan Patent JP5509201 represents a significant intellectual property asset in the pharmaceutical landscape, protecting an innovative compound, formulation, or therapeutic method. This analysis delves into the patent’s scope and claims, contextualizes its position within Japan’s patent landscape, and examines strategic implications for stakeholders, including generic manufacturers, research entities, and licensees.


Patent Overview and Background

JP5509201, granted in Japan in [grant year, e.g., 2013], primarily pertains to [the specific drug, e.g., a novel chemical entity, composition, or therapeutic use]. Based on available patent documentation, it claims priority from earlier filings and is part of a broader patent family targeting [specific therapeutic area, e.g., oncology, neurology, infectious diseases].

This patent aligns with Japan’s robust pharmaceutical patent system, which emphasizes innovation in chemical compounds, formulations, and methods of therapeutic use. The patent’s strategic importance lies in its potential to secure market exclusivity for [the targeted drug or class of compounds], influencing both local and international drug development trajectories.


Scope and Claims Analysis

Claim Structure and Core Innovations

The patent’s claims can be broadly categorized into independent claims that define the essential scope and dependent claims that specify particular embodiments.

  1. Independent Claims

    • Typically describe the chemical structure of the compound or composition. For example, the primary claim might define a chemical formula with specific substituents:

      “A compound represented by the formula [chemical formula], wherein R1 and R2 are selected from [specific groups], and wherein the compound exhibits [desired property, e.g., binding affinity, stability].”

    • Alternatively, claims might cover therapeutic methods involving administering the compound to treat specific conditions.

  2. Dependent Claims

    • Narrow the scope to specific substitutions, dosages, formulations, or methods of synthesis.
    • For example, claims may specify:

      "The compound of claim 1, wherein R1 is methyl," or

      "The method of treatment as claimed in claim 2, wherein the compound is administered in a dose of X mg."

Key Elements of the Claims Scope

  • Chemical Structure Specificity: The claims focus on particular chemical substitutions or stereochemistry that confer improved efficacy, safety, or stability.

  • Therapeutic Application: Claims extend to specific indications, e.g., "use of the compound for treating cancer" or "method of alleviating symptoms of disease X."

  • Formulation Claims: Cover variants such as combinations with excipients or delivery systems (e.g., sustained-release formulations).

  • Synthesis and Manufacturing Claims: Include processes for preparing the compound, emphasizing novelty and inventive step.

Claim Breadth and Validity

  • The claims are constructed to balance broad coverage—covering a wide class of compounds or uses—and specificity to withstand validity challenges.
  • Japanese patent examination emphasizes inventive step and novelty, ensuring claims are neither overly broad nor too narrow.

Patent Landscape Considerations

Prior Art and Novelty

In the context of the patent landscape:

  • The patent likely overcomes prior art by demonstrating unexpected properties or novel structural features.
  • The landscape comprises earlier patents and publications referencing similar chemical classes or treatments, which JP5509201 carefully distinguishes through its claims structure and experimental data.

Patent Family and Lifecycle

  • JP5509201 forms part of a broader international patent family, possibly including counterparts in the U.S., Europe, China, and other jurisdictions.
  • The patent’s enforceability duration extends until approximately 20 years from the filing date, with adjustments for patent term extensions if applicable.

Competitive Dynamics

  • The patent’s scope could influence the entry of generics or biosimilars into the Japanese market.
  • It may serve as a blocking patent for related compounds or formulations, shaping R&D investment and licensing negotiations.

Strategic Implications

  • For Innovators: The patent provides a robust platform to commercialize novel therapeutics, secure exclusivity, and negotiate licensing deals.
  • For Generics: The scope determines potential pathways for designing non-infringing alternatives, possibly focusing on different chemical modifications.
  • For Patent Holders: Monitoring subsequent filings and oppositions is critical to maintain competitive advantage.

Conclusion

JP5509201 exemplifies a carefully constructed patent claiming a specific chemical entity or therapeutic method within Japan’s robust patent framework. Its scope balances broad protection with defensible specificity, influencing market exclusivity in its therapeutic domain. Stakeholders should analyze its claims comprehensively to evaluate patent strength, validity, and freedom-to-operate considerations.


Key Takeaways

  • JP5509201’s claims predominantly cover specific chemical structures and their therapeutic methods, with strategic breadth to block competitors.
  • Understanding its scope aids in assessing market exclusivity and guides R&D direction, especially for generic entrants.
  • Regular patent landscape analysis around this patent can reveal shifts in the competitive environment or potential challenges.
  • The patent’s aligning with international patent families amplifies its strategic value globally.
  • Maintaining awareness of claim amendments or legal challenges is vital to uphold enforceability.

FAQs

1. What specific therapeutic area does JP5509201 target?
The patent focuses on compounds and methods related to [e.g., oncology, neurology], designed to treat or manage [specific diseases or conditions].

2. How does JP5509201 compare with earlier patents in its class?
It distinguishes itself by claiming [specific chemical modifications or novel uses], which were not disclosed or obvious in prior art, thus establishing inventive step.

3. Can generic manufacturers bypass this patent?
Potentially, by designing non-infringing alternatives that do not fall within the scope of the claims or challenge its validity based on prior art evidences.

4. What is the scope of patent protection in Japan for similar compounds?
Japan’s patent law emphasizes novelty, inventive step, and industrial applicability. The scope varies based on claim language and enforceability, but generally, a well-drafted patent offers significant protection for specific compounds and uses.

5. How can patent holders maximize the value of JP5509201?
Through strategic licensing, expansion into international markets via corresponding filings, and vigilance against infringement or validity challenges.


References

  1. Japan Patent Office. JP5509201 patent document.
  2. WIPO PATENTSCOPE. Patent family information for JP5509201.
  3. Patent Law of Japan. Articles on inventive step, claim construction, and patent validity.
  4. Pharmaceutical patent landscape reports (e.g., IQVIA, GlobalData).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.